SLP  valuation analysis

Basics
Name: Simulations Plus, Inc
Description: Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. (more)
Industry: Health Information Services
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Jan 11, 2021
Market cap: $1.24B (1070th)
Sales(TTM): $42.89M (1256th)
Earnings(TTM): $9.75M (927th)

Value
FFER: 2.45 (why)
Actual price: $62.25
FFEThis is Simulations Plus, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $34.66
Quantile: SLP is very expensive given its fundamentals.
Prices as of EOD 2021-03-04
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Simulations Plus, Inc
"Health Information Services" industry
Sales / MarketCap
Simulations Plus, Inc
"Health Information Services" industry
Book / MarketCap
Simulations Plus, Inc
"Health Information Services" industry
Equity / Assets
Simulations Plus, Inc
"Health Information Services" industry